SKI Market

Indian Indices

Nifty

25,574.35 82.05
(0.32%)

Sensex

83,535.35 319.07
( 0.38%)

Bank Nifty

57,937.55 60.75
( 0.10%)

Nifty IT

35,688.25 570.65
( 1.62%)

Global Indices

Nasdaq

16.76 83.45
(0.18%)

Dow Jones

6,751.11 9.79
(0.15%)

Hang Seng

50,901.74 625.37
(1.24%)

Nikkei 225

9,688.02 -47.76
(-0.49%)

Forex

USD-INR

88.62 -0.02
(-0.03%)

EUR-INR

102.12 0.31
(0.30%)

GBP-INR

116.02 0.48
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

48.1

950.03

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.09

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	79.16	63.94	45.03	24.72	18.42	11.92
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	79.16	63.94	45.03	24.72	18.42	11.92
Other Income	2.91	2.81	1.58	0.72	0.81	0.85
Stock Adjustments	0.23	1.53	-1.30	0.44	0.71	0.40
Total Income	82.30	68.28	45.31	25.88	19.94	13.17
EXPENDITURE :
Raw Materials	35.27	29.21	20.14	12.71	12.21	7.44
Power & Fuel Cost	0.04	0.00	0.00	0.00	0.00	0.01
Employee Cost	9.17	6.51	5.47	3.42	2.95	2.86
Other Manufacturing Expenses	3.73	4.05	4.57	2.02	0.00	0.26
Selling & Administrative Expenses	4.82	4.45	2.98	2.70	0.00	1.37
Miscellaneous Expenses	0.38	0.25	0.02	0.17	3.17	0.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	53.41	44.47	33.18	21.02	18.33	11.93
Operating Profit	28.89	23.81	12.12	4.86	1.61	1.24
Interest	0.38	0.34	0.23	0.09	0.03	0.04
Gross Profit	28.51	23.47	11.89	4.77	1.58	1.20
Depreciation	1.87	1.12	0.48	0.15	0.18	0.11
Profit Before Tax	26.64	22.35	11.41	4.62	1.40	1.09
Tax	6.67	6.41	3.00	1.19	0.37	0.31
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.07	-0.68	-0.09	-0.01	-0.02	-0.02
Reported Net Profit	19.90	16.62	8.50	3.43	1.06	0.81
Extraordinary Items	0.15	0.00	0.00	0.01	0.08	0.00
Adjusted Net Profit	19.75	16.62	8.50	3.42	0.98	0.81
Adjustment below Net Profit	-4.43	0.00	-0.20	-0.99	0.00	0.00
P & L Balance brought forward	29.81	13.78	5.58	3.13	2.07	1.20
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.18	0.59	0.00	0.00	0.00	0.00
P & L Balance carried down	44.10	29.81	13.89	5.58	3.13	2.01
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	15.00	60.00	20.00	0.00	0.00	0.00
Dividend Per Share(Rs)	1.50	6.00	2.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	33.79	113.06	78.37	34.34	1059.50	811.60
Earnings Per Share(Adj)-Unit Curr	16.90	14.13	78.37	34.34	1059.50	811.60
Book Value-Unit Curr	411.24	1044.56	176.36	65.78	3143.70	2020.30
Book Value(Adj)-Unit Curr	205.62	130.57	176.36	65.78	3143.70	2020.30

25,574.35 82.05 (0.32%)

83,535.35 319.07 ( 0.38%)

57,937.55 60.75 ( 0.10%)

35,688.25 570.65 ( 1.62%)

16.76 83.45 (0.18%)

6,751.11 9.79 (0.15%)

50,901.74 625.37 (1.24%)

9,688.02 -47.76 (-0.49%)

88.62 -0.02 (-0.03%)

102.12 0.31 (0.30%)

116.02 0.48 (0.42%)

0.58 0.00 (0.14%)